Diakonos Oncology Corp., a Houston, TX-based clinical-stage biotechnology company developing a new generation of immunotherapies to treat challenging and aggressive cancers, closed a $ 20m private placement of Simple Agreements for Future Equity (SAFE). The financing included backing by new investors Baylor College of Medicine (BCM), the Brain Tumor Investment Fund (BTIF), and the Buttonwood Titan QC Fund, with additional participation […]
The post Diakonos Oncology Raises $ 20M in Funding appeared first on FinSMEs.
